Finance

Lists
531015:BOM
Venmax Drugs and Pharmaticals Ltd
₹14,89
-0,87%
(-0,13) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531015...
Open
₹15,02
High
₹16,00
Low
₹14,36
Mkt. cap
215,67 m
Avg. vol.
11,88 k
Volume
3,93 k
P/E ratio
36,77
52-wk high
₹31,49
52-wk low
₹12,71
EPS
₹0,40
No. of employees
2
Open
₹15,02
High
₹16,00
Low
₹14,36
Mkt. cap
215,67 m
Avg. vol.
11,88 k
Volume
3,93 k
P/E ratio
36,77
52-wk high
₹31,49
52-wk low
₹12,71
EPS
₹0,40
No. of employees
2
News stories
From web sources and news partners
About Venmax Drugs and Pharmaticals Ltd
CEO-
Employees2
Founded1988
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
13,18 m
15,52 m
39,44 m
24,79 m
Cost of goods sold
11,44 m
14,10 m
36,39 m
22,48 m
Cost of revenue
11,44 m
14,10 m
36,39 m
22,48 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
612,00 k
347,00 k
672,00 k
542,00 k
Operating expense
1,28 m
1,67 m
2,23 m
1,15 m
Total operating expenses
12,73 m
15,78 m
38,62 m
23,63 m
Operating income
458,00 k
-253,00 k
823,00 k
1,16 m
Other non operating income
-300,00
682,00 k
-683,00 k
3,00 k
EBT including unusual items
451,70 k
429,00 k
1,51 m
1,16 m
EBT excluding unusual items
451,70 k
429,00 k
1,51 m
1,16 m
Income tax expense
207,70 k
108,00 k
-29,00 k
-1,00 k
Effective tax rate
45,98%
25,17%
-1,92%
-0,09%
Other operating expenses
661,00 k
1,32 m
1,55 m
594,00 k
Net income
244,00 k
321,00 k
1,54 m
1,17 m
Net profit margin
1,85%
2,07%
3,91%
4,70%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,37 m
-
Interest expense
-6,00 k
-
-
-
Net interest expenses
-6,00 k
-
1,37 m
-
Depreciation and amortization charges
10,00 k
10,00 k
10,00 k
13,00 k
EBITDA
468,00 k
-243,00 k
833,00 k
1,18 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme